US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 4.000
  • +0.090+2.30%
Close Feb 28 16:00 ET
  • 4.000
  • 0.0000.00%
Post 20:01 ET
119.05MMarket Cap-7.21P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
102,753.86%1.27M
102,753.86%1.27M
33,939.07%834.64K
12,777.91%1.88M
--3.27M
-13.25%1.23K
--1.23K
--2.45K
--14.63K
--1.42K
-Cash and cash equivalents
102,753.86%1.27M
102,753.86%1.27M
33,939.07%834.64K
12,777.91%1.88M
--3.27M
-13.25%1.23K
--1.23K
--2.45K
--14.63K
--1.42K
Receivables
--0
--0
0.00%130K
--130K
--130K
--130K
--130K
--130K
----
--0
-Related party accounts receivable
--0
--0
0.00%130K
--130K
--130K
--130K
--130K
--130K
----
--0
Prepaid assets
8,016.97%57.87K
8,016.97%57.87K
7,931.88%77.35K
--87.81K
--98.81K
--713
--713
--963
----
--0
Current deferred assets
--0
--0
--0
--0
--0
541.04%303.28K
--303.28K
--102.89K
--81.44K
--47.31K
Total current assets
204.21%1.32M
204.21%1.32M
340.94%1.04M
2,087.79%2.1M
--3.5M
793.14%435.23K
--435.23K
--236.31K
--96.07K
--48.73K
Non current assets
Related parties assets
--0
--0
0.00%130K
--130K
--130K
--130K
--130K
--130K
----
--0
Non current deferred assets
--0
--0
--0
--0
--0
--4.34M
--4.34M
--5.08M
--5.83M
--0
Total non current assets
--0
--0
--0
--0
--0
--4.34M
--4.34M
--5.08M
--5.83M
--0
Total assets
-72.26%1.32M
-72.26%1.32M
-80.41%1.04M
-64.51%2.1M
--3.5M
9,696.36%4.77M
--4.77M
--5.32M
--5.92M
--48.73K
Liabilities
Current liabilities
Payables
-44.84%680.97K
-44.84%680.97K
-66.47%599.91K
-65.42%534.16K
--486.55K
25.21%1.23M
--1.23M
--1.79M
--1.54M
613.82%986.01K
-accounts payable
-16.92%587.54K
-16.92%587.54K
2.11%506.48K
-53.43%393.81K
--478.65K
74.95%707.19K
--707.19K
--496.03K
--845.58K
2,057.57%404.22K
-Due to related parties current
-82.28%93.43K
-82.28%93.43K
-92.77%93.43K
-79.93%140.34K
--7.9K
-9.35%527.38K
--527.38K
--1.29M
--699.13K
387.28%581.79K
Current accrued expenses
----
----
----
----
----
----
----
--13.52K
--94
----
Current debt and capital lease obligation
----
----
----
----
----
--101K
--101K
--1.34M
--487.91K
----
-Current debt
----
----
----
----
----
--101K
--101K
--1.34M
--487.91K
----
Current liabilities
-49.01%680.97K
-49.01%680.97K
-80.90%599.91K
-73.72%534.16K
--486.55K
35.45%1.34M
--1.34M
--3.14M
--2.03M
613.82%986.01K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-49.01%680.97K
-49.01%680.97K
-80.90%599.91K
-73.72%534.16K
--486.55K
35.45%1.34M
--1.34M
--3.14M
--2.03M
613.82%986.01K
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-117.55%-30.6M
-117.55%-30.6M
-484.74%-27.7M
-619.45%-21.77M
---20.32M
-1,317.36%-14.06M
---14.06M
---4.74M
---3.03M
-618.36%-992.28K
Paid-in capital
78.49%31.24M
78.49%31.24M
306.95%28.14M
237.46%23.34M
--23.34M
31,722.45%17.5M
--17.5M
--6.92M
--6.92M
0.00%55K
Total stockholders'equity
-81.30%643.04K
-81.30%643.04K
-79.70%442.07K
-59.70%1.57M
--3.02M
466.83%3.44M
--3.44M
--2.18M
--3.89M
-578.54%-937.28K
Total equity
-81.30%643.04K
-81.30%643.04K
-79.70%442.07K
-59.70%1.57M
--3.02M
466.83%3.44M
--3.44M
--2.18M
--3.89M
-578.54%-937.28K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 102,753.86%1.27M102,753.86%1.27M33,939.07%834.64K12,777.91%1.88M--3.27M-13.25%1.23K--1.23K--2.45K--14.63K--1.42K
-Cash and cash equivalents 102,753.86%1.27M102,753.86%1.27M33,939.07%834.64K12,777.91%1.88M--3.27M-13.25%1.23K--1.23K--2.45K--14.63K--1.42K
Receivables --0--00.00%130K--130K--130K--130K--130K--130K------0
-Related party accounts receivable --0--00.00%130K--130K--130K--130K--130K--130K------0
Prepaid assets 8,016.97%57.87K8,016.97%57.87K7,931.88%77.35K--87.81K--98.81K--713--713--963------0
Current deferred assets --0--0--0--0--0541.04%303.28K--303.28K--102.89K--81.44K--47.31K
Total current assets 204.21%1.32M204.21%1.32M340.94%1.04M2,087.79%2.1M--3.5M793.14%435.23K--435.23K--236.31K--96.07K--48.73K
Non current assets
Related parties assets --0--00.00%130K--130K--130K--130K--130K--130K------0
Non current deferred assets --0--0--0--0--0--4.34M--4.34M--5.08M--5.83M--0
Total non current assets --0--0--0--0--0--4.34M--4.34M--5.08M--5.83M--0
Total assets -72.26%1.32M-72.26%1.32M-80.41%1.04M-64.51%2.1M--3.5M9,696.36%4.77M--4.77M--5.32M--5.92M--48.73K
Liabilities
Current liabilities
Payables -44.84%680.97K-44.84%680.97K-66.47%599.91K-65.42%534.16K--486.55K25.21%1.23M--1.23M--1.79M--1.54M613.82%986.01K
-accounts payable -16.92%587.54K-16.92%587.54K2.11%506.48K-53.43%393.81K--478.65K74.95%707.19K--707.19K--496.03K--845.58K2,057.57%404.22K
-Due to related parties current -82.28%93.43K-82.28%93.43K-92.77%93.43K-79.93%140.34K--7.9K-9.35%527.38K--527.38K--1.29M--699.13K387.28%581.79K
Current accrued expenses ------------------------------13.52K--94----
Current debt and capital lease obligation ----------------------101K--101K--1.34M--487.91K----
-Current debt ----------------------101K--101K--1.34M--487.91K----
Current liabilities -49.01%680.97K-49.01%680.97K-80.90%599.91K-73.72%534.16K--486.55K35.45%1.34M--1.34M--3.14M--2.03M613.82%986.01K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -49.01%680.97K-49.01%680.97K-80.90%599.91K-73.72%534.16K--486.55K35.45%1.34M--1.34M--3.14M--2.03M613.82%986.01K
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -117.55%-30.6M-117.55%-30.6M-484.74%-27.7M-619.45%-21.77M---20.32M-1,317.36%-14.06M---14.06M---4.74M---3.03M-618.36%-992.28K
Paid-in capital 78.49%31.24M78.49%31.24M306.95%28.14M237.46%23.34M--23.34M31,722.45%17.5M--17.5M--6.92M--6.92M0.00%55K
Total stockholders'equity -81.30%643.04K-81.30%643.04K-79.70%442.07K-59.70%1.57M--3.02M466.83%3.44M--3.44M--2.18M--3.89M-578.54%-937.28K
Total equity -81.30%643.04K-81.30%643.04K-79.70%442.07K-59.70%1.57M--3.02M466.83%3.44M--3.44M--2.18M--3.89M-578.54%-937.28K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Cars.com
CARS
+9.73%
Lantheus
LNTH
+2.55%
Halozyme Therapeutics
HALO
+2.51%
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+2.27%
Collegium Pharmaceutical
COLL
+2.22%

Unlock the Full List